• Products
    • INSB200 ™
    • INSB400 ™
  • Leadership
  • News & Events
  • Contact
InSitu Biologics Announces Co-Development Agreement With Mayo Clinic

InSitu Biologics Announces Co-Development Agreement With Mayo Clinic

by InSitu Biologics | Dec 22, 2022 | News & Updates

InSitu Biologics is pleased to announce that it has entered into an agreement with the Mayo Clinic to further develop its prolonged-release drug delivery technology for anti-cancer therapeutics. For more details regarding this announcement, please take some time to...
InSitu Biologics Shares Latest Investigational Work at ASRA Meeting

InSitu Biologics Shares Latest Investigational Work at ASRA Meeting

by InSitu Biologics | Nov 17, 2022 | News & Updates

InSitu Biologics will share the latest investigational work on its multi-phase drug delivery matrix at the upcoming 21st Annual Pain Medicine Meeting of the American Society of Regional Anesthesia on November 18th, 2022. For more details regarding this announcement,...
InSitu Biologics Welcomes Dr. M. Yaman to Medical Advisory Board

InSitu Biologics Welcomes Dr. M. Yaman to Medical Advisory Board

by InSitu Biologics | Apr 22, 2022 | News & Updates, Uncategorized

InSitu Biologics is very pleased to announce the appointment of Dr. M. Yaman, FRCS, FACS, to its Medical Advisory Board. For more details regarding this announcement, please take some time to read the below press release. Click Here to...
InSitu Biologics Shares Results at American Society of Regional Anesthesia Pain Meeting

InSitu Biologics Shares Results at American Society of Regional Anesthesia Pain Meeting

by InSitu Biologics | Mar 30, 2022 | News & Updates

InSitu Biologics will share the latest investigational work on its hydrogel-lipid-microparticle matrix at the upcoming 47th Annual Regional and Acute Pain Medicine Meeting of the American Society of Regional Anesthesia in April 2022. For more details regarding this...
InSitu Biologics Welcomed Into UAE in5 Incubator

InSitu Biologics Welcomed Into UAE in5 Incubator

by InSitu Biologics | Mar 14, 2022 | News & Updates

InSitu Biologics was formally welcomed into in5, one of the UAE’s leading incubators, last month by in5’s Board of Directors. In5 specializes in supporting tech, media, and design startups. For more details about this development, please take some time to...

Recent Posts

  • InSitu Biologics Announces Co-Development Agreement With Mayo Clinic
  • InSitu Biologics Shares Latest Investigational Work at ASRA Meeting
  • InSitu Biologics Welcomes Dr. M. Yaman to Medical Advisory Board
  • InSitu Biologics Shares Results at American Society of Regional Anesthesia Pain Meeting
  • InSitu Biologics Welcomed Into UAE in5 Incubator

Categories

  • General
  • News & Updates
  • Uncategorized

© Copyright 2023 | InSitu Biologics | All Rights Reserved
Developed by UNiO Branding